Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposureAssociations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese populationDifferentiation and selection of hepatocyte precursors in suspension spheroid culture of transgenic murine embryonic stem cellsHepatic Cytochrome P450 Activity, Abundance, and Expression Throughout Human DevelopmentAlternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Clinical therapeutics in pregnancy.Chemical exposure as etiology in developmental origin of adult onset human cancer.Clomipramine concentration and withdrawal symptoms in 10 neonates.Drug Interactions at the Human Placenta: What is the Evidence?Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4Determination of Deoxynivalenol in the Urine of Pregnant Women in the UK.Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy.Independent Maternal and Fetal Genetic Effects on Midgestational Circulating Levels of Environmental Pollutants.ABCB1 and ABCG2 expression in the placenta and fetus: an interspecies comparison.Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents.Foetal exposure to food and environmental carcinogens in human beings.The role of the placenta in fetal exposure to heavy metals.Genetic and Epigenetic Mechanisms Linking Air Pollution and Congenital Heart Disease.ATP-binding cassette proteins BCRP, MRP1 and P-gp expression and localization in the human umbilical cord.Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.Clozapine Use During Pregnancy and Lactation: A Case-Series Report.Deoxynivalenol exposure assessment in a cohort of pregnant women from Bradford, UK.Drug development for use during pregnancy: impact of the placenta
P2860
Q26741187-676C7282-9EE3-4A4E-80D2-F563448A79A2Q28385768-A5C3CC82-1B54-4CEF-A149-76F1DB639551Q28395070-35BBAE1C-ACC7-4E70-BA18-54C19E04E961Q28483972-CDB8D0FD-6F37-4436-8C42-866DE1C164D1Q28831360-6F6E5F8E-414F-44B7-8B5C-907B49176797Q34181630-8B9F0400-7F92-4680-BA5E-E00DA22BF648Q35113890-64A4F254-0682-4B03-B486-F284C5CFF9EFQ35619948-3D38C36D-719D-4463-A162-B92BEDBDA142Q35718651-1AE11003-73C1-44E3-AC95-9A51B696191CQ36081992-FE825D9D-96FE-42CD-9C5C-7F774A6B8C01Q36306228-C5C82374-F879-45B0-9750-1427EC501610Q36390289-A9A5844B-E486-4ECA-96EB-226B948E5EBBQ37450350-86B495E8-20A4-4F70-8940-D5CA6D1BAD77Q37742091-A6BA415D-2811-4CC2-AE63-13E18AD544A8Q37746498-30DED745-16DD-451C-BFAC-EAEE699D35D2Q37782354-8652B6FD-51FC-43BF-88B5-1ADD556D8066Q37830057-EB0724B6-4E34-4CA3-A26A-3EAC6F9DB663Q37899282-DE703FE7-F8E0-473E-906F-40C344496260Q38020353-1AC81E28-493E-4953-AB11-A9E9AAC4525FQ48196490-529A27BD-E6EF-470A-90F1-C367CE5D31DFQ50559062-E520A729-EFB6-458F-863B-E034DFA1B612Q50597914-CB8F7C96-9608-4418-9F20-CD98BBEDD8D5Q52595228-58F1D98A-CFAF-4CD2-AD97-4B9D6B45E573Q52845894-02330862-C1B0-480E-AA14-030E00EDAA25Q58392274-969E51F3-3F9D-476D-9144-3E9E49D5C687
P2860
Developmental expression of drug metabolizing enzymes and transporter proteins in human placenta and fetal tissues.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Developmental expression of dr ...... an placenta and fetal tissues.
@en
Developmental expression of dr ...... an placenta and fetal tissues.
@nl
type
label
Developmental expression of dr ...... an placenta and fetal tissues.
@en
Developmental expression of dr ...... an placenta and fetal tissues.
@nl
prefLabel
Developmental expression of dr ...... an placenta and fetal tissues.
@en
Developmental expression of dr ...... an placenta and fetal tissues.
@nl
P2093
P2860
P1476
Developmental expression of dr ...... an placenta and fetal tissues.
@en
P2093
Elina Immonen
Kirsi Vähäkangas
Maria Kummu
Päivi Myllynen
P2860
P304
P356
10.1517/17425250903304049
P407
P577
2009-12-01T00:00:00Z